JNJ
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals
Johnson & Johnson
$271.03
+1.04 (+0.39%)
Analyst Consensus
Buy
31
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+10.5% upside
Low Target
$223.02
Average Target
$299.55
High Target
$400.15
Current Price
$271.03
Current
$271.03
$271.03
Target
$299.55
$299.55
$223.02
$299.55 avg
$400.15
Scenario Analysis
Bear Case
$223.02
-17.7%
Low target
Base Case
$299.55
+10.5%
Avg target
Bull Case
$400.15
+47.6%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$281.07
-3.6% from high
52-Week Low
$173.33
+56.4% from low
50-Day SMA
$219.25
+23.6% vs SMA
200-Day SMA
$185.17
+46.4% vs SMA
RSI (14)
88.6
Overbought
Target vs 52W High
$299.55
+6.6% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +14.0% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +10.5% |
| MRK | Buy | 36 | 72% | $159.27 | +6.1% |
| PFE | Hold | 36 | 39% | $33.90 | +21.5% |
| BMY | Hold | 35 | 43% | $174.50 | +177.1% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -37.9% |
| ZTS | Hold | 24 | 50% | $209.87 | +193.9% |